The current form of the American Health Care Act would greatly impact patients in New Orleans, where a high percentage of people have chronic diseases that count as preexisting conditions, explained Michael Griffin, president and CEO of Daughters of Charity Services.
The current form of the American Health Care Act would greatly impact patients in New Orleans, where a high percentage of people have chronic diseases that count as preexisting conditions, explained Michael Griffin, president and CEO of Daughters of Charity Services.
Transcript
If the American Health Care Act is passed in its current form, what impact would it have on individuals that you serve in the New Orleans area?
Well the first question is "in its current form." So the form keeps changing every day and as we are here in Arizona, the debate is happening on the current replace/repeal effort. As I understand it today, part of this debate is about preexisting conditions that are part of the Affordable Care Act and that are covered, as well as the individual mandates are a portion, there's also some discussion about Medicaid expansion and whether individuals can stay on expanded Medicaid even if they get off and get back on.
And so all of those things will effect us heavily. My patient population, I have a very high percentage of chronically ill patients. So they already have preexisting conditions—hypertensive, asthmatic, diabetic patients—and I can say upwards of 50% of my patient base would be impacted by today's debate on preexisting conditions. If those preexisting conditions go into a higher risk pool or something that the state has to cover, we're in a very poor state in Louisiana, and being one of the less wealthy states that coverage would not happen for my patient population.
Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending
August 19th 2025Hospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.
Read More
Roflumilast Cream 0.05% Durable, Safe for Younger Pediatric Patients
August 15th 2025The INTEGUMENT-OLE study is an open-label extension analysis that followed a primary investigation from the phase 3 INTEGUMENT-PED trial, which investigated the efficacy and safety of once-daily roflumilast cream 0.05% for atopic dermatitis in children aged 2 to 5 years.
Read More
PCPs Have Unique Opportunity to Detect, Manage CKD
August 14th 2025As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, training, and collaborative frameworks needed for optimal management is a public health priority, emphasize the researchers.
Read More
Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions
August 13th 2025More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older age, multiple comorbidities, and more than 2000 potential drug-to-drug interactions.
Read More